Opportunity Information: Apply for PA 11 273
Apply for PA 11 273
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Advancing the Impact of Effective HIV/AIDS Prevention and Treatment Interventions (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242 Mental Health Research Grants.
- This funding opportunity was created on Jul 26, 2011 and posted on Jul 26, 2011.
- Applicants must submit their applications by May 7, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: For profit organizations other than small businesses County governments Independent school districts City or township governments Special district governments Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Public housing authorities/Indian housing authorities Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education State governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
Advancing the Impact of Effective HIV/AIDS Prevention and Treatment Interventions (R21) is a National Institutes of Health (NIH) grant opportunity issued by the Division of AIDS Research (DAR) within the National Institute of Mental Health (NIMH). The main purpose of the announcement is to support innovative, early stage research that makes proven HIV prevention and HIV treatment interventions work better in real-world settings and reach the people who need them most. Instead of focusing on inventing entirely new interventions, the emphasis is on increasing the public health impact of interventions that already have evidence behind them, especially by addressing the practical, behavioral, social, and systems level barriers that keep effective approaches from being widely used.
The FOA is built around a clear implementation oriented problem: there is often a large gap between interventions that succeed in controlled research studies and what happens when clinics, communities, and public health programs try to use those interventions at scale. NIMH frames this as part of its broader strategic goal to strengthen the real-world public health impact of mental health related research, including HIV related behavioral and service delivery science. Projects are expected to use research, evaluation, and collaboration to close that gap, meaning applicants should think about adoption, integration into existing services, feasibility, sustainability, and reach among priority populations, not just efficacy under ideal conditions.
This opportunity is aligned with major federal HIV planning priorities, including the National HIV/AIDS Strategy and the NIH Office of AIDS Research (OAR) Plan for HIV/AIDS Related Research. In practice, that means the program is meant to accelerate progress on national goals like reducing new infections, improving access to care and health outcomes for people living with HIV, and reducing HIV related disparities. Research topics under this umbrella can include strategies to improve uptake, adherence, retention in care, linkage to services, and consistent delivery of effective prevention tools, as well as approaches that strengthen service systems and community delivery platforms. Because the announcement comes from NIMH, proposals that incorporate behavioral, social, and mental health related factors that influence prevention and treatment implementation are especially relevant.
The grant mechanism is an R21, which typically supports exploratory and developmental work that may be higher risk but has the potential for strong payoff. The listed award ceiling is $200,000. There is no cost sharing or matching requirement, which reduces barriers for applicants who may not have additional funds to contribute. The program is categorized under Health, with CFDA number 93.242 (Mental Health Research Grants), reflecting NIMH sponsorship and the behavioral and implementation science angle of the work.
Eligibility is broad and intentionally inclusive. Applicants may include public and private institutions of higher education, nonprofits (including both 501(c)(3) and non-501(c)(3) organizations), for-profit organizations (including small businesses), and a wide range of government entities such as state, county, city or township, special district governments, and independent school districts. Tribal governments and tribal organizations are eligible, including both federally recognized and other than federally recognized tribal entities, along with tribally controlled colleges and universities. The announcement also explicitly welcomes participation from organizations serving historically underrepresented groups, such as HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian serving institutions, and faith-based or community-based organizations. Importantly, non-U.S. (foreign) institutions are eligible to apply, and non-U.S. components of U.S. organizations are also eligible, signaling an openness to global HIV implementation questions where lessons may generalize or where the burden is high.
Administratively, the funding opportunity number is PA-11-273, and it was posted on July 26, 2011. The original and final closing date listed is May 7, 2014, with an archive date of June 7, 2014, meaning the announcement is no longer active as a current competition but remains useful as a record of NIMH priorities and as a reference point for similar, newer NIH opportunities. The archived full announcement is linked through the NIH grants site at http://grants.nih.gov/grants/guide/pa-files/PA-11-273.html. For access or technical issues with the online posting, the contact provided is the NIH Office of Extramural Research webmaster (FBOWebmaster@OD.NIH.GOV).
Overall, the FOA is best understood as a call for practical, innovative research that helps effective HIV prevention and treatment interventions achieve greater real-world reach and effectiveness, with an explicit goal of moving evidence-based strategies from research settings into routine, scalable use among populations and communities most affected by HIV.
Frequently Asked Questions (FAQs)
What is the name of this NIH funding opportunity?
The funding opportunity is titled Advancing the Impact of Effective HIV/AIDS Prevention and Treatment Interventions (R21).
Which NIH institute and program are associated with this FOA?
This opportunity is issued by the National Institutes of Health (NIH) through the Division of AIDS Research (DAR) within the National Institute of Mental Health (NIMH).
What is the FOA number?
The funding opportunity number is PA-11-273.
What is the primary purpose of this grant opportunity?
The primary purpose is to support innovative, early stage research that helps proven HIV prevention and HIV treatment interventions work better in real-world settings and reach the people who need them most. The emphasis is on increasing the public health impact of interventions that already have evidence behind them.
Is this opportunity meant to fund brand-new HIV interventions?
No. The emphasis is not on inventing entirely new interventions. Instead, it focuses on improving the real-world use, reach, and impact of existing evidence-based HIV prevention and treatment interventions by addressing barriers to adoption and scale.
What problem is this FOA trying to address?
The FOA is built around an implementation-oriented problem: there is often a large gap between interventions that succeed in controlled research studies and what happens when clinics, communities, and public health programs try to implement those interventions at scale. Projects are expected to help close that gap.
What kinds of barriers or challenges does the FOA emphasize?
The FOA highlights practical barriers that limit widespread use of effective interventions, including behavioral, social, practical, and systems-level barriers that interfere with adoption, integration, feasibility, sustainability, and reach.
What research orientation does NIMH emphasize in this FOA?
The FOA is strongly oriented toward implementation in real-world settings. Applicants are expected to consider factors such as adoption, integration into existing services, feasibility, sustainability, and reach among priority populations, not only whether an intervention works under ideal conditions.
How does this FOA connect to federal HIV priorities?
This opportunity is aligned with major federal HIV planning priorities, including the National HIV/AIDS Strategy and the NIH Office of AIDS Research (OAR) Plan for HIV/AIDS Related Research. It is meant to accelerate progress toward goals like reducing new infections, improving access to care and outcomes for people living with HIV, and reducing HIV-related disparities.
What topic areas are described as relevant under this umbrella?
The description includes strategies to improve uptake, adherence, retention in care, linkage to services, and consistent delivery of effective prevention tools, as well as approaches that strengthen service systems and community delivery platforms.
Why does the FOA highlight behavioral, social, and mental health factors?
Because the announcement is issued by NIMH, proposals that incorporate behavioral, social, and mental health-related factors influencing prevention and treatment implementation are described as especially relevant.
What grant mechanism is used for this opportunity?
The mechanism is an R21, which typically supports exploratory and developmental research that may be higher risk but could have strong payoff.
What is the award ceiling listed for this R21 opportunity?
The listed award ceiling is $200,000.
Is cost sharing or matching required?
No. The opportunity explicitly states there is no cost sharing or matching requirement.
What is the program category and CFDA number?
The program is categorized under Health with CFDA number 93.242 (Mental Health Research Grants), reflecting NIMH sponsorship and the behavioral/implementation science angle.
Who is eligible to apply?
Eligibility is described as broad and inclusive. Eligible applicants include:
- Public and private institutions of higher education
- Nonprofits, including 501(c)(3) and non-501(c)(3) organizations
- For-profit organizations, including small businesses
- Government entities such as state, county, city or township, special district governments, and independent school districts
- Tribal governments and tribal organizations, including federally recognized and other than federally recognized tribal entities
- Tribally controlled colleges and universities
Does the FOA encourage applications from historically underrepresented or community-based organizations?
Yes. The announcement explicitly welcomes participation from organizations serving historically underrepresented groups, including HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian serving institutions, and faith-based or community-based organizations.
Are non-U.S. (foreign) institutions eligible?
Yes. The description states that non-U.S. (foreign) institutions are eligible to apply, and that non-U.S. components of U.S. organizations are also eligible.
When was this FOA posted?
The FOA was posted on July 26, 2011.
What were the closing date and archive date?
The original and final closing date listed is May 7, 2014, and the archive date is June 7, 2014.
Is this funding opportunity still active?
No. Based on the listed closing and archive dates, the announcement is no longer active as a current competition. It remains available as an archived record of priorities and as a reference point for similar or newer NIH opportunities.
Where can the archived full announcement be found?
The archived full announcement is available through the NIH grants site at: http://grants.nih.gov/grants/guide/pa-files/PA-11-273.html
Who is listed as the contact for access or technical issues with the online posting?
For access or technical issues with the online posting, the contact provided is the NIH Office of Extramural Research webmaster at FBOWebmaster@OD.NIH.GOV.
In plain terms, what types of projects fit this FOA best?
Projects fit best when they focus on practical, innovative research that helps evidence-based HIV prevention and treatment interventions achieve greater real-world reach and greater effectiveness in routine practice, especially among populations and communities most affected by HIV, by addressing implementation barriers and improving delivery systems.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: Advancing the Impact of Effective HIV/AIDS Prevention and Treatment Interventions (R34)
Previous opportunity: Advancing the Impact of Effective HIV/AIDS Prevention and Treatment Interventions (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 11 273
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 11 273) also looked into and applied for these:
| Funding Opportunity |
|---|
| Advancing the Impact of Effective HIV/AIDS Prevention and Treatment Interventions (R34) Apply for PAR 11 274 Funding Number: PAR 11 274 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Advancing the Impact of Effective HIV/AIDS Prevention and Treatment Interventions (R03) Apply for PA 11 272 Funding Number: PA 11 272 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| International Research Collaboration on Alcohol and Alcoholism (U01) Apply for PAR 11 282 Funding Number: PAR 11 282 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Consumer Operated and Oriented Plan Apply for OO COO 11 001 Funding Number: OO COO 11 001 Agency: CMS Consumer Information Insurance Oversight Category: Health Funding Amount: Case Dependent |
| Frontier Community Health Integration Demonstration Apply for HRSA 11 202 Funding Number: HRSA 11 202 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Frontier Extended Stay Clinic Cooperative Agreement Apply for HRSA 11 139 Funding Number: HRSA 11 139 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Planning Grants for Clinical Trials of High Relevance to the NIGMS Mission (R34) Apply for PAR 11 287 Funding Number: PAR 11 287 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Functional Restoration of Salivary Glands (R21) Apply for RFA DE 12 005 Funding Number: RFA DE 12 005 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Functional Restoration of Salivary Glands (R01) Apply for RFA DE 12 004 Funding Number: RFA DE 12 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Paul B. Beeson Clinical Scientist Development Award in Aging (K08) Apply for RFA AG 12 003 Funding Number: RFA AG 12 003 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Paul B. Beeson Patient Oriented Research Career Development Award in Aging (K23) Apply for RFA AG 12 004 Funding Number: RFA AG 12 004 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Bridges to the Baccalaureate Program (R25) Apply for PAR 11 285 Funding Number: PAR 11 285 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Institutional Career Development Award for Enhancing Research Capacity in Temporomandibular Joint Disorders and Orofacial Pain (K12) Apply for PAR 11 289 Funding Number: PAR 11 289 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Phase I/II Preliminary Clinical Trials in Communication Disorders (R01) Apply for PAR 11 290 Funding Number: PAR 11 290 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Aging Research Dissertation Awards to Increase Diversity (R36) Apply for PAR 11 291 Funding Number: PAR 11 291 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Secondary Analyses and Archiving of Social and Behavioral Datasets in Aging (R03) Apply for RFA AG 12 005 Funding Number: RFA AG 12 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Human Cell Reprogramming for Aging and Alzheimers Disease Research (R21) Apply for RFA AG 12 008 Funding Number: RFA AG 12 008 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| COMMUNITY BASED LIVELIHOOD DEVELOPMENT FOR WOMEN AND CHILDREN (C BLD) IN SWAZILAND Apply for RFA 674 11 0042 Funding Number: RFA 674 11 0042 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $5,820,000 |
| T2 Translational Research on Aging Small Business Innovation Awards (R43/R44) Apply for RFA AG 12 010 Funding Number: RFA AG 12 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| T1 Translational Research on Aging Small Business Innovation Awards (R43/R44) Apply for RFA AG 12 009 Funding Number: RFA AG 12 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 11 273", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.